Trial Profile
Long-term study of SMP-862 in patients with paediatric type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jan 2017
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 25 May 2016 New trial record